CD4 and Hepatitis: Owing to its low sensitivity, classifying patients as CD4+ TEM<21% has limited clinical utility; however, specifically identifying cases at high-risk of hepatitis before treatment is useful from a research perspective because we can then prospectively study the immunological basis of their predisposition.